T1	Participants 65 77	colon cancer
T2	Participants 169 219	1990 for patients undergoing colectomy for cancer.
T3	Participants 541 624	48 institutions and randomly assigned 872 patients with adenocarcinoma of the colon
T4	Participants 2383 2395	colon cancer
